Harbour Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,925
| Closed | -$289K | – | 310 |
|
|
2025
Q1 | $289K | Buy |
+4,925
| New | +$289K | 0.07% | 228 |
|
|
2023
Q3 | – | Sell |
-3,140
| Closed | -$356K | – | 278 |
|
|
2023
Q2 | $356K | Hold |
3,140
| – | – | 0.11% | 176 |
|
|
2023
Q1 | $432K | Buy |
3,140
+260
| +9% | +$35.8K | 0.13% | 150 |
|
|
2022
Q4 | $360K | Buy |
+2,880
| New | +$360K | 0.12% | 158 |
|
|
2020
Q4 | – | Sell |
-8,050
| Closed | -$1.13M | – | 168 |
|
|
2020
Q3 | $1.13M | Buy |
8,050
+60
| +0.8% | +$8.42K | 0.41% | 70 |
|
|
2020
Q2 | $1.28M | Hold |
7,990
| – | – | 0.52% | 60 |
|
|
2020
Q1 | $782K | Sell |
7,990
-3,528
| -31% | -$345K | 0.4% | 76 |
|
|
2019
Q4 | $1.49M | Sell |
11,518
-1,802
| -14% | -$232K | 0.57% | 64 |
|
|
2019
Q3 | $1M | Buy |
13,320
+2,740
| +26% | +$206K | 0.42% | 79 |
|
|
2019
Q2 | $1.61M | Buy |
10,580
+2,582
| +32% | +$392K | 0.69% | 54 |
|
|
2019
Q1 | $953K | Sell |
7,998
-660
| -8% | -$78.6K | 0.42% | 80 |
|
|
2018
Q4 | $945K | Buy |
8,658
+83
| +1% | +$9.06K | 0.47% | 78 |
|
|
2018
Q3 | $1.39M | Buy |
8,575
+320
| +4% | +$51.7K | 0.56% | 56 |
|
|
2018
Q2 | $1.11M | Buy |
8,255
+5,225
| +172% | +$704K | 0.48% | 80 |
|
|
2018
Q1 | $224K | Buy |
+3,030
| New | +$224K | 0.1% | 227 |
|
|
2016
Q3 | – | Sell |
-17,550
| Closed | -$335K | – | 274 |
|
|
2016
Q2 | $335K | Hold |
17,550
| – | – | 0.19% | 168 |
|
|
2016
Q1 | $343K | Buy |
+17,550
| New | +$343K | 0.2% | 156 |
|